Skip to main content
. Author manuscript; available in PMC: 2020 Apr 24.
Published in final edited form as: J Am Chem Soc. 2019 Apr 15;141(16):6453–6457. doi: 10.1021/jacs.8b13681

Figure 2.

Figure 2.

Drug combination studies using the different arsenic trioxide: cisplatin ratios in the triple negative breast MDA-MB231 cancer cell line. The combination index (CI) values significantly less than 1 are found in all cases confirming strong synergy between the two drugs. The best results are obtained for arsenic trioxide to cisplatin ratio of 1:1.